Neurogene Inc
Ownership
Ownership Structure
Who owns Neurogene Inc (NGNE)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 56.6% of the shares are freely tradable; institutional investors hold 110.6%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Samsara BioCapital, LLC | 8.58 | 1,717,127 | +0.0 | 06/30/2026 |
| Casdin Capital, LLC | 7.72 | 1,545,361 | +8.8 | 06/30/2026 |
| Redmile Group, LLC | 7.06 | 1,412,199 | -3.2 | 06/30/2026 |
| RTW INVESTMENTS, LLC | 6.81 | 1,362,456 | +0.0 | 03/31/2026 |
| EcoR1 Capital, LLC | 6.35 | 1,271,342 | +0.0 | 06/30/2026 |
| BlackRock Inc | 5.02 | 1,005,070 | +6.3 | 03/31/2026 |
| Baker Bros Advisors LP | 4.96 | 991,691 | +0.0 | 03/31/2026 |
| Balyasny Asset Management LLC | 3.59 | 718,389 | +18.0 | 03/31/2026 |
| Trails Edge Capital Partners, LP | 3.57 | 714,885 | -8.7 | 06/30/2026 |
| The Toronto-Dominion Bank | 3.40 | 681,337 | +0.0 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.